Peptides for Growth Hormone
Overview
2 research peptides are currently studied for growth hormone. This guide ranks them by evidence strength and covers their mechanisms, safety profiles, and current clinical status.
Ghrelin — Well-characterized endogenous hormone with approved analogs
Evidence Rating: B Category: Growth Hormone / Appetite
Ghrelin is a 28-amino acid peptide hormone produced primarily by the stomach that serves as the endogenous ligand for the growth hormone secretagogue receptor (GHS-R1a). It is the only known circulating orexigenic (appetite-stimulating) hormone. Ghrelin stimulates growth hormone release, increases a...
Key claims: Stimulates growth hormone release; Potent appetite stimulation.
CJC-1295 with DAC — Phase I-II data; research compound
Evidence Rating: C Category: Growth Hormone
CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone-releasing hormone (GHRH) analog with a unique lysine-linked maleimidopropionic acid moiety that covalently binds to circulating albumin in vivo. This albumin binding extends the half-life from minutes (native GHRH) to approximate...
Key claims: Sustained growth hormone elevation; Convenient weekly dosing schedule.
Related Products
CJC-1295 DAC 5mg
5mg
Related Research News
CJC-1295 with DAC and Ipamorelin: Growth Hormone Research Guide
CJC-1295 with DAC and Ipamorelin represent key compounds in growth hormone research, targeting distinct pathways for GH and IGF-1 signaling. CJC-1295 with DAC acts as a long-acting GHRH analogue with a half-life of 5.8 to 8.1 days, while Ipamorelin functions as a selective growth hormone secretagogue via the ghrelin receptor. Together, they support studies on metabolism, recovery, and body composition.
Ipamorelin vs GHRP-2: Which Offers More Targeted GH Release?
Ipamorelin and GHRP-2 both stimulate growth hormone release via the ghrelin receptor, but Ipamorelin provides more selective action with minimal impact on other hormones like ACTH and cortisol. GHRP-2 delivers stronger GH pulses alongside broader endocrine effects. Combining them can enhance overall GH output through additive receptor stimulation.